August 19, 2025

Neck Swelling, Dysphagia, and Jaw Pain: What’s Your Diagnosis?

A rare carotid artery pseudoaneurysm complicated by MRSA infection, septic arthritis, and an incidental thigh tumor challenged clinicians but was successfully treated with surgery and targeted antibiotics.

Conexiant

August 13, 2025

Medical Oddities: Spud Alert, Method Matters Most

Science spans snacks, cells, sheep, and sips in this week’s research highlights.

Conexiant

August 08, 2025

Neuroimaging Study Reveals SuperAging Brain Traits

Superagers aged 80 years and older demonstrate a unique neurobiological profile associated with successful aging: preserved memory and distinct brain anatomy, including thicker cortical regions and lower tau pathology.

Conexiant

August 07, 2025

Allogeneic Islet Transplant Shows Promise Without Immunosuppression

First-in-human trial shows genetically engineered islet cells restore insulin secretion in type 1 diabetes without triggering immune rejection.

Conexiant

August 06, 2025

Could Saliva Replace Blood for Cancer Screening?

Ultra-sensitive Bluetooth biosensor detects breast cancer markers HER2 and CA15-3 in saliva within one second

Conexiant

August 04, 2025

New Guidelines Recommend Blood-Based Biomarkers in Alzheimer's Dx

"The panel urges clinicians to consider the pretest probability of AD pathology for each patient when deciding whether or not to use a BBM test,” and not as a standalone diagnostic tool.

Conexiant

August 04, 2025

Beta-HPV–Driven SCC Resolved After TCR Signaling Correction

Case study shows cutaneous squamous cell carcinoma linked to beta-human papillomavirus cleared following T-cell immune restoration.

Conexiant

July 23, 2025

6 Blood Proteins Predict Kidney Function Decline

A 6-protein blood-based model predicted kidney function decline in patients with ADPKD more accurately than clinical or imaging-based models, and offers a new pathway for outcome prediction.

Conexiant

July 23, 2025

FDA Grants Breakthrough Status to Melanoma Test

The FDA has granted Breakthrough Device designation to Castle Biosciences’ DecisionDx-Melanoma test, a gene expression profile assay designed to improve risk stratification and personalized care in cutaneous melanoma.

Conexiant